UKs University of Birmingham researchers have just been awarded £3.5 million funding from Johnson & Johnson to investigate mechanisms of response and non-response to biologic and targeted synthetic therapies in rheumatoid arthritis. https://t.co/or9amYqljz https://t.co/EvDhVfqOig
Links:
Significant funding to ensure personalized treatments that work for rheumatoid …
https://buff.ly/4gJO2pk
Jan-07-2025
